OncClubAll Oncology NewsPipeline Report
InsightsMedical World NewsOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsThe Talk
Conference CoverageConference Listing
Giants of Cancer CarePER EventsScientific InterchangesState of the Science Summit / IPCWebinars
Partners
Oncology Live®Oncology FellowsSupplements And Featured PublicationsAll Publications
CME/CE
Interactive ToolsLearning ModulesPresentationsSponsored
Biomarker Consortium
Print SubscriptioneNewsletter
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
Spotlight -
  • 2024 nominations are open for Giants of Cancer Care®
  • In-person and virtual events just for HCPs
  • REGISTER TODAY to explore data on a novel second-generation BTK inhibitor for adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
  • Share your views with OncChats
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
    • Partners
    • CME/CE
    • Biomarker Consortium
Advertisement

“Breast Cancer Talk” Contemporary Concepts: Systemic Therapy for Breast Cancer

home / the-talk / breast-cancer-talk-contemporary-concepts-systemic-therapy-for-breast-cancer

Advertisement
Metastatic HR+ Breast Cancer

EP. 1: Metastatic HR+ Breast Cancer

By Sarah Sammons, MD, Duke Cancer Institute
Julie Collins, MD, MedStar Georgetown University Hospital
  • Kelly McCann, MD, PhD, Ronald Reagan UCLA Medical Center
  • Laura Spring, MD, Massachusetts General Hospital
September 16th 2020
Metastatic HER2+ Breast Cancer

EP. 2: Metastatic HER2+ Breast Cancer

By Sarah Sammons, MD, Duke Cancer Institute
Julie Collins, MD, MedStar Georgetown University Hospital
  • Kelly McCann, MD, PhD, Ronald Reagan UCLA Medical Center
  • Laura Spring, MD, Massachusetts General Hospital
September 16th 2020
HER2+ Early-Stage Breast Cancer: Peri-Operative Therapy

EP. 3: HER2+ Early-Stage Breast Cancer: Peri-Operative Therapy

By Sarah Sammons, MD, Duke Cancer Institute
Julie Collins, MD, MedStar Georgetown University Hospital
  • Kelly McCann, MD, PhD, Ronald Reagan UCLA Medical Center
  • Laura Spring, MD, Massachusetts General Hospital
September 16th 2020
Precision Medicine in Metastatic Triple Negative Breast Cancer

EP. 4: Precision Medicine in Metastatic Triple Negative Breast Cancer

By Sarah Sammons, MD, Duke Cancer Institute
Julie Collins, MD, MedStar Georgetown University Hospital
  • Kelly McCann, MD, PhD, Ronald Reagan UCLA Medical Center
  • Laura Spring, MD, Massachusetts General Hospital
September 16th 2020

Latest Conference Coverage

Second-Line Axi-Cel Prolongs Survival Over SOC in Elderly Patients With R/R LBCL

Venetoclax Is Associated With Durable ORRs in Real-World Population of BTK Inhibitor–Exposed CLL/SLL

Ultrasensitive BCMA CARs Deliver Responses With Tolerable Safety in R/R Multiple Myeloma

Golidocitinib Demonstrates Efficacy in Relapsed/Refractory PTCL

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact